Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology. [PDF]
Agoulnik IU +8 more
europepmc +1 more source
Nanobodies unlock new mechanisms to target G protein-coupled receptors. [PDF]
Skiba MA.
europepmc +1 more source
Relaxin-2-secreting CAR-T cells exhibit enhanced efficacy in stromal-rich xenograft tumors. [PDF]
Ogawa H +4 more
europepmc +1 more source
Advancing Isotope Labeling Technologies at AstraZeneca through Academic-Industrial Collaboration. [PDF]
Bragg RA +5 more
europepmc +1 more source
G protein-coupled receptors in prostate cancer: research progress and therapeutic targets. [PDF]
Xiong W, Zhou B, Shi J, Ni D, Xiong Z.
europepmc +1 more source
KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification. [PDF]
Zhang Z, Guo J, Gong C, Wu S, Sun Y.
europepmc +1 more source
Relaxin-2 Exhibits a Beneficial Role in Energy Metabolism to Alleviate Atrial Fibrillation Susceptibility. [PDF]
Zhao X +9 more
europepmc +1 more source
KIAA1429 in non-small cell lung cancer: bridging m6A epigenetics to therapeutic innovation. [PDF]
Liu H +7 more
europepmc +1 more source
Development of Diphenyl-1,2,4-Oxadiazole Analogues as Allosteric Modulators of the RXFP3 Receptor: Evaluation of Importance of the N-Substituted-2-Pyrrolidone Moiety in RLX-33. [PDF]
Guan D +9 more
europepmc +1 more source
Diet-Driven Microglial Activation: Region-Specific Neuroinflammation in the Mouse Brain. [PDF]
Plantera L +5 more
europepmc +1 more source

